Both products deliver dry powder asthma medication through Teva’s RespiClick inhaler.
The AirDuo RespiClick contains the same active ingredients as GlaxoSmithKline’s inhaler drug Advair, while the ArmonAir RespiClick contains the same active ingredients as GSK’s other asthma drug Flovent. Both inhalers are intended to treat asthma in adults 12 years and older.
Teva expects both products to be available in the U.S. later this year.
More articles on supply chain:
Target launches new guidelines to control chemicals in its supply chain
Shark antibodies could successfully transport drugs to brain
Mylan CEO speaks out for 1st time since congressional hearing: 5 quotes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.